1
Leitao Eugenia Ribeiro de Sous: Implant material and process for producing it. Matrix Medical, November 12, 1997: EP0806211-A1 (51 worldwide citation)

The invention provides a nanotechnology process for implant surface treatment for producing an implant article. The nanotechnology process comprises subjecting a non-porous material to a mechanical or chemical surface treatment until a surface roughness with an average peak distance (Ra value) betwe ...


2
Leitao Eugenia Ribeiro de Sous, de Bruijn Joost Dick, Wen Hai Bo, de Groot Klaas: Device for incorporation and release of biologically active agents. Matrix Medical, November 12, 1997: EP0806212-A1 (41 worldwide citation)

The invention provides an implantable device coated with a layer of calcium phosphate and optionally one or more biologically active substances such as growth factors, lipis, (lipo)polysaccharides, hormones, proteins, antibiotics or cytostatics. The device can be obtained by a nanotechnology process ...


3
Schankereli Kemal, Dieck Ronald: Biocompatible phase invertable proteinaceous compostions and methods for making and using the same. Matrix Medical, Schankereli Kemal, Dieck Ronald, FIELD Bret E, February 12, 2004: WO/2004/012678 (17 worldwide citation)

Biocompatible phase invertable proteinaceous compositions and methods for making and using the same are provided. The subject phase invertable compositions are prepared by combining a proteinaceous substrate and a cross-linker. The proteinaceous substrate includes one or more proteins and an adhesio ...


4
Kemal Schankereli, Ronald Dieck: Biocompatible phase invertable proteinaceous compositions and methods for making and using the same. Matrix Medical, Bret E Field, Bozicevic Field & Francis, December 4, 2007: US07303757 (13 worldwide citation)

Biocompatible phase invertable proteinaceous compositions and methods for making and using the same are provided. The subject phase invertable compositions are prepared by combining a proteinaceous substrate and a cross-linker. The proteinaceous substrate includes one or more proteins and an adhesio ...


5
Van Blitterswijk Clemens Anton, de Bruijn Joost Dick, Bovell Yvonne Pearl: Method for in vitro production of bone. Matrix Medical, October 1, 1997: EP0798374-A1 (7 worldwide citation)

The invention relates to a method for in vitro production of bone tissue, comprising the steps of: (a) applying undifferentiated mammalian cells, in particular autologous marrow cells, on a substrate: (b) directly contacting said cells with a culture medium for a sufficient time to produce a continu ...


6
Surya Ramachandran, Anand Kancherlapalli: Multi-agent collaborative architecture for problem solving and tutoring. Aidentity Matrix Medical, Piper Rudnick, February 10, 2004: US06690914 (5 worldwide citation)

An architecture for a computer system for problem solving and tutoring includes multiple domain dependent agents, each having a knowledge base, multiple domain independent agents and dedicated blackboards assigned to each agent. The agents communicate with their dedicated blackboards via a transmiss ...


7
Kemal Schankereli, Ronald Dieck: Biocompatible phase invertable proteinaceous compositions and methods for making and using the same. Matrix Medical, Bret E Field, Bozicevic Field & Francis, January 18, 2011: US07871639 (2 worldwide citation)

Biocompatible phase invertable proteinaceous compositions and methods for making and using the same are provided. The subject phase invertable compositions are prepared by combining a proteinaceous substrate and a cross-linker. The proteinaceous substrate includes one or more proteins and an adhesio ...


8
Kemal Schankereli, Ronald Dieck: Biocompatible phase invertable proteinaceous compositions and methods for making and using the same. MATRIX MEDICAL, August 11, 2015: US09101536

Biocompatible phase invertible proteinaceous compositions and methods for making and using the same are provided. The subject phase invertible compositions are prepared by combining a proteinaceous substrate and a crosslinking agent, such as a stabilized aldehyde crosslinking agent. Also provided ar ...


9
Kemal Schankereli, Ronald Dieck: Biocompatible phase invertible proteinaceous compositions and methods for making and using the same. Matrix Medical, Bret E Field, Benjamin C Pelletier, Bozicevic Field & Francis, January 8, 2013: US08349348

Biocompatible phase invertible proteinaceous compositions and methods for making and using the same are provided. The subject phase invertible compositions are prepared by combining a proteinaceous substrate and a crosslinking agent, such as a stabilized aldehyde crosslinking agent. Also provided ar ...


10
Schankereli Kemal, Dieck Ronald: Biocompatible phase invertable proteinaceous compostions and methods for making and using the same. Matrix Medical, June 29, 2005: EP1545411-A2

Biocompatible phase invertable proteinaceous compositions and methods for making and using the same are provided. The subject phase invertable compositions are prepared by combining a proteinaceous substrate and a cross-linker. The proteinaceous substrate includes one or more proteins and an adhesio ...